Sg Americas Securities, LLC Fate Therapeutics Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 34,363 shares of FATE stock, worth $68,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,363

Previous 36,372 5.52%

Holding current value

$68,726

Previous $119,000 0.84%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$3.12 - $5.57 $6,268 - $11,190	-2,009 Reduced 5.52%	34,363 $120,000
Q2 2024 Jul 12, 2024	SELL	$3.26 - $7.08 $3,533 - $7,674	-1,084 Reduced 2.89%	36,372 $119,000
Q1 2024 May 06, 2024	SELL	$3.54 - $8.35 $187,963 - $443,359	-53,097 Reduced 58.64%	37,456 $275,000
Q4 2023 Jan 12, 2024	BUY	$1.65 - $3.94 $27,903 - $66,629	16,911 Added 22.96%	90,553 $339,000
Q3 2023 Oct 13, 2023	BUY	$2.02 - $5.04 $148,756 - $371,155	73,642 New	73,642 $156,000
Q1 2023 Apr 28, 2023	BUY	$4.24 - $11.12 $46,640 - $122,319	11,000 New	11,000 $63,000
Q2 2022 Jul 29, 2022	SELL	$17.78 - $42.39 $1.63 Million - $3.88 Million	-91,629 Reduced 87.51%	13,076 $324,000
Q1 2022 Apr 29, 2022	SELL	$29.67 - $60.28 $9.36 Million - $19 Million	-315,485 Reduced 75.08%	104,705 $4.06 Million
Q4 2021 Feb 07, 2022	BUY	$47.84 - $64.34 $17.4 Million - $23.4 Million	363,576 Added 642.2%	420,190 $24.6 Million
Q3 2021 Nov 01, 2021	BUY	$59.27 - $95.73 $209,993 - $339,171	3,543 Added 6.68%	56,614 $3.36 Million
Q2 2021 Aug 12, 2021	BUY	$67.25 - $92.52 $2.38 Million - $3.27 Million	35,372 Added 199.85%	53,071 $4.61 Million
Q1 2021 May 13, 2021	BUY	$72.16 - $117.4 $1.07 Million - $1.74 Million	14,820 Added 514.76%	17,699 $1.46 Million
Q4 2020 Feb 04, 2021	SELL	$38.09 - $100.95 $2.83 Million - $7.51 Million	-74,392 Reduced 96.27%	2,879 $262,000
Q3 2020 Nov 09, 2020	BUY	$30.41 - $40.5 $2.22 Million - $2.95 Million	72,860 Added 1651.78%	77,271 $3.09 Million
Q2 2020 Jul 20, 2020	SELL	$20.21 - $35.23 $424,895 - $740,675	-21,024 Reduced 82.66%	4,411 $151,000
Q1 2020 Apr 30, 2020	BUY	$17.28 - $31.88 $439,516 - $810,867	25,435 New	25,435 $565,000
Q2 2019 Jul 29, 2019	SELL	$15.61 - $20.44 $150,433 - $196,980	-9,637 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$13.15 - $18.71 $126,726 - $180,308	9,637 New	9,637 $169,000
Q4 2017 Jan 24, 2018	SELL	$3.94 - $6.64 $41,748 - $70,357	-10,596 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$2.6 - $4.31 $27,549 - $45,668	10,596	10,596 $42,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $194M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Fate Therapeutics Inc Transaction History